| scholarly article | Q13442814 |
| P50 | author | Michael R Keegan | Q93383863 |
| P2093 | author name string | Mark Nelson | |
| Chris Higgs | |||
| Dietmar Fuchs | |||
| Alan Winston | |||
| Adriano Boasso | |||
| P2860 | cites work | The excitatory amino acid antagonist kynurenic acid administered after hypoxic-ischemia in neonatal rats offers neuroprotection | Q57982919 |
| Simultaneous measurement of serum tryptophan and kynurenine by HPLC | Q61906305 | ||
| Decreased whole blood 5-hydroxytryptamine (serotonin) in AIDS patients | Q68014739 | ||
| A phase IV, double-blind, multicentre, randomized, placebo-controlled, pilot study to assess the feasibility of switching individuals receiving efavirenz with continuing central nervous system adverse events to etravirine | Q33448696 | ||
| Anti-retroviral therapy decreases but does not normalize indoleamine 2,3-dioxygenase activity in HIV-infected patients | Q33830637 | ||
| The kynurenine pathway of tryptophan catabolism, CD4+ T-cell recovery, and mortality among HIV-infected Ugandans initiating antiretroviral therapy | Q34106235 | ||
| Expression of the kynurenine pathway enzymes in human microglia and macrophages | Q34327818 | ||
| Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons | Q34351574 | ||
| Neuropharmacology of quinolinic and kynurenic acids | Q34728770 | ||
| Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder | Q35366778 | ||
| PharmGKB summary: Efavirenz pathway, pharmacokinetics | Q35706069 | ||
| Dendritic spine injury induced by the 8-hydroxy metabolite of efavirenz | Q36406259 | ||
| Antiretroviral neurotoxicity | Q36635673 | ||
| The human indoleamine 2,3-dioxygenase gene and related human genes | Q36789436 | ||
| How does indoleamine 2,3-dioxygenase contribute to HIV-mediated immune dysregulation. | Q36789448 | ||
| Assessment of the Human Kynurenine Pathway: Comparisons and Clinical Implications of Ethnic and Gender Differences in Plasma Tryptophan, Kynurenine Metabolites, and Enzyme Expressions at Baseline and After Acute Tryptophan Loading and Depletion | Q37167902 | ||
| Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel | Q37234729 | ||
| Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment Among HIV-infected Individuals | Q37372353 | ||
| Psychiatric Symptoms in Patients Receiving Dolutegravir | Q37659135 | ||
| Implications of efavirenz for neuropsychiatry: a review. | Q37801927 | ||
| Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease?. | Q38271657 | ||
| Mood, food, and cognition: role of tryptophan and serotonin | Q38631293 | ||
| Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and beta 2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients | Q41094880 | ||
| Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection | Q43418119 | ||
| Immune activation and decreased tryptophan in patients with HIV-1 infection. | Q43673162 | ||
| More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC. | Q43893230 | ||
| Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection | Q44128933 | ||
| Indole amine deficiency in blood and cerebrospinal fluid from patients with human immunodeficiency virus infection | Q45847119 | ||
| Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid | Q48634830 | ||
| Kynurenic acid metabolism in the brain of HIV-1 infected patients | Q49134173 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | efavirenz | Q422645 |
| dolutegravir | Q937224 | ||
| P304 | page(s) | 85-90 | |
| P577 | publication date | 2018-11-26 | |
| P1433 | published in | Journal of NeuroVirology | Q6295640 |
| P1476 | title | Tryptophan metabolism and its relationship with central nervous system toxicity in people living with HIV switching from efavirenz to dolutegravir | |
| P478 | volume | 25 |
Search more.